Medipal Holdings announced a share buyback program capped at 4 million shares and ¥10 billion. The company also plans to cancel the shares acquired, with the purchase period running from 6 November 2026 to 31 March 2027.
Medipal Holdings is posting sharp gains for the fifth straight day. The current price is ¥3,377, up ¥171 from the previous day, drawing increased investor interest.
The company announced on 23 October that it would establish a share buyback program capped at 4 million shares and ¥10 billion. The purchase period runs from 6 November 2026 to 31 March 2027, and the shares acquired at the maximum amount would represent 2.0% of shares outstanding.
The company also announced that it would cancel all shares acquired through the buyback. Up to 4 million shares will be cancelled. The cancellation is scheduled to take place after the buyback ends and by 31 March 2027.